Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CRX.L (CRX) Share News

Cyprotex Warns On Full Year Amid Development Delays, Weak Demand

14th Nov 2014 07:53

Read More

Cyprotex Launches Improved Version Of SenCeeTox Technology

14th Oct 2014 09:11

Read More

Cyprotex Now Able To Offer Full Range Of In Vitro Drug Transporter Assays

9th Oct 2014 08:30

Read More

Cyprotex Buys New Instruments To Expand Toxicology Facility

1st Oct 2014 08:22

Read More

Cyrpotex: In Vitro Skin Sensitisation Test Using KeratinoSens Launched

9th Sep 2014 08:54

Read More

Cyprotex Joins Comprehensive In Vitro Proarrythmia Assay Initiative

4th Sep 2014 08:46

Read More

Cyprotex Swings To Loss On Acquisitions Costs; Gross Margin Falls

28th Aug 2014 12:33

Read More

Cyprotex Seeks Loan Note Listing On Cayman Islands Stock Exchange

21st Aug 2014 08:58

Read More

UK MORNING BRIEFING: Reed Elsevier Leads Blue Chips On Bullish Outlook

24th Jul 2014 07:41

Read More

Cyprotex Proposes One-For-Ten Share Consolidation

3rd Jul 2014 08:01

Read More

UK MORNING BRIEFING: Tullow Oil Strikes Oil Offshore Norway

3rd Jul 2014 07:33

Read More

Cyprotex Adds New Instruments At Alderley Park Site

1st Jul 2014 10:21

Read More

DIRECTOR DEALINGS: Cyprotex Non-Executive Buys 400,000 Shares

4th Jun 2014 10:59

LONDON (Alliance News) - Cyprotex PLC Wednesday said Non-Executive Director Steve Harris bought 400,000 shares at a price of 6.4 pence per share. Following this transaction, Harris holds 2 million shares, which represents 0.89% stake in the firm. Shares in the biotech company were up Read More

Cyprotex Swings To Pretax Loss Despite Revenue Increase

25th Mar 2014 14:33

LONDON (Alliance News) - Cyprotex PLC Tuesday said it swung to a pretax loss in 2013 as higher costs and an exceptional charge relating to loan notes it issued more than offset increased revenues. The preclinical discovery and development contract research organisation posted a pretax loss Read More

M&A Statistics: London AIM Market

28th Jan 2014 16:13

Read More

UK MIDDAY BRIEFING: Pearson Plunges After Profit Warning

23rd Jan 2014 13:48

LONDON (Alliance News) - Publisher Pearson is the biggest faller on the FTSE 100 Thursday after it issued a profit warning, saying trading had been weaker than it expected, particularly in North America, its main market. The Financial Times owner and publisher of education books said it had Read More

Cyprotex Warns Of Swing To Pretax Loss On Finance Charges

23rd Jan 2014 12:12

LONDON (Alliance News) - Shares in Cyprotex PLC dropped by more than a fifth Thursday after it said that it expects to post a pretax loss for 2013 due to finance charges related to its redeemable loan notes and convertible loan notes with Trident Private Equity Fund III LLP. The research or Read More

UK WINNERS & LOSERS: Pearson, EasyJet Lead Blue-Chip Fallers

23rd Jan 2014 12:00

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS London Stock Exchange, up 1.1%. The company said its third-quarter revenue increased by 52% year-on-year, buoyed by recentl Read More

UK MORNING BRIEFING: Pearson Warns On 2013, As China Data Disappoints

23rd Jan 2014 08:19

LONDON (Alliance News) - Shares have opened lower Thursday following disappointing PMI figures from China. Financial and education publisher <strong>Pearson</strong> is down 5.9% at the open after saying its 2013 performance was weaker than expected, particularly in North America.<br />< Read More

Cyprotex Acquires Business And Assets Of CeeTox

2nd Jan 2014 10:16

Read More

FTSE 100 Latest
Value8,809.74
Change53.53